Navigation Links
Surgery Without the Knife: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
Date:3/24/2017

BOTHELL, Wash., March 23, 2017 /PRNewswire/ -- Mirabilis Medical, a Seattle-area developer of advanced medical technology for non-invasive surgery, announced today CE Mark authorization for marketing of the Mirabilis System for treatment of uterine fibroids throughout the European Union.  The company simultaneously announced that it had received approval from the US Food and Drug Administration to begin a clinical study of the Mirabilis System in the United States.  The Mirabilis System combines high-speed therapeutic ultrasound technology with an advanced robotic system to allow treatments to be finished within minutes in a medical office setting.

Fibroids are benign tumors of the uterus that can substantially impact the quality of a woman's life, causing heavy and prolonged menstrual bleeding, pelvic cramps, urinary frequency and urgency, and pregnancy loss or infertility.  Approximately 25% of all women suffer from symptomatic uterine fibroids at some point in their lives, with annual U.S. spending on fibroid treatment exceeding $2.1 billion according to the National Institutes of Health.  Over 40% of all hysterectomies (surgical removal of the uterus) are performed to treat fibroids.

The Mirabilis System for non-invasive treatment of uterine fibroids.
The Mirabilis System for non-invasive treatment of uterine fibroids.

Current treatments for uterine fibroids typically involve an invasive surgical procedure that can include destroying the uterine lining to reduce bleeding (endometrial ablation), cutting out the fibroids (myomectomy), and hysterectomy.  In addition to the cost, surgical risk, and recovery time of such procedures, they often result in infertility.

The Mirabilis System treats uterine fibroids non-invasively by focusing ultrasound energy into the fibroids from outside the body – no cutting is involved.  The procedure is performed by a physician placing the Mirabilis System on a woman's abdomen, locating the fibroid using built-in ultrasound imaging, and selecting the area of the fibroid to be treated.  Under physician control, the device then automatically treats the fibroid using a robotic motion system.  Proprietary Mirabilis technology allows typical treatments to be completed in less than ten minutes in a medical office, as opposed to several hours in a hospital for some alternatives.

"The Mirabilis System has been in development for nearly ten years, and it's very exciting to now be able to bring this technology to market," said Jens U. Quistgaard, President and CEO of Mirabilis.  "This technology holds the promise of helping a large number of women worldwide, and we're very pleased to be able to begin making it available."

The Mirabilis System is currently restricted to investigational use in the United States, however, the company expects to begin a clinical study later this year intended to lead to US marketing approval.  The Mirabilis DIANA study is planned to be conducted at 12 clinical sites in the US, Canada, and Europe. 

Media Contact:

Jens U. Quistgaard

(425) 486-8230 x210

jens@mirabilismed.com

Related Links

Company Website

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/surgery-without-the-knife-mirabilis-medical-announces-european-approval-for-non-invasive-uterine-fibroid-treatment-300428867.html


'/>"/>
SOURCE Mirabilis Medical, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Arizona Center for Reconstructive Breast Surgery Patients To Benefit From Innovative Fluorescence Imaging Technology
2. Ethicon And DePuy Synthes Introduce Customized Wound Closure Kits Aiming To Improve Efficiencies And Patient Outcomes In Orthopaedic Surgery
3. Global Vitreoretinal Surgery Device Market - Forecasted to Grow at a CAGR of 5.20% During 2016-2021 - Driven by Increasing Penetration in Emerging Economies - Research and Markets
4. Surgery Exchange Launches Enhanced Cloud-Based Platform to Help Providers Control Costs of Implant Surgeries
5. 78% Stroke Reduction with Newer No-Touch Beating Heart Bypass Surgery, According to Landmark Study
6. Drug-Eluting Stents Market 2015-2022 - Global Strategic Business Report 2017 - High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents - Research and Markets
7. Flower Orthopedics Launches FlowerAdvantage, an Ambulatory Surgery Center Efficiency and Savings Partnership
8. Europe Market Report for Neurosurgery Navigation Systems 2017 - MedCore
9. Plastic Surgery and Integumentary System Market is Predicted to Grow at a CAGR of 13% from 2016 to 2022
10. New Data in the Journal of Neurosurgery Reinforce use of Elektas Gamma Knife in Hypofractionated Radiosurgery to Treat Large or Complex Brain Tumors
11. 7D Surgical Receives FDA 510(K) and Health Canada MDL Clearance for Its Breakthrough Image Guidance System for Spine Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):